European Journal of Inorganic Chemistry
10.1002/ejic.201600971
FULL PAPER
(d, J = 8.2 Hz, 1H), 7.18 – 6.92 (broad signal, 2H), 6.26 (d, J =
chromatography on silica gel with DCM - acetone (20 : 1) as
eluent provided a product as a pale yellow oil (245 mg, 15 %).
1H NMR (400 MHz, Chloroform-d) δ 8.60 (s, 1H), 8.06 (s, 1H),
7.59 (d, J = 8.5 Hz, 1H), 6.59 (m, 2H), 3.86 (s, 3H), 3.85 (s, 3H).
1-(2’,4’-dimethoxyphenyl)-4-methyl1,2,4-triazol- iodide (8). 1-
(2’,4’-dimethoxyphenyl)-1,2,4-triazole (245 mg, 1.2 mmol), CH3I
(400 mg, 2.8 mmol) and THF (4 mL) were mixed in high
pressure flask equipped with a stirring bar. The flask was
8.2 Hz, 1H), 3.85 (s, 3H), 3.84 (s, 3H).
1-(2’,6’-dimethoxy-3-pyridine)-3-methyl-imidazolium iodide (4).
The synthetic procedure is analogous to the synthesis of 1-(2’,4’-
dimethoxyphenyl)-3-methylimidazolium iodide. 3 (1.46 g, 7.2
mmol), CH3I (1.53 g, 10.8 mmol) and acetonitrile (30 mL) were
used. Recrystallization from acetone-hexane afforded the
product (2.15 g, 86 %) as a pale violet crystals. 1H NMR (400
MHz, Acetonitrile-d3) δ 8.90 (s, 1H), 7.81 (d, J = 8.5 Hz, 1H),
7.62 (d, J = 1.9 Hz, 1H), 7.55 (d, J = 1.8 Hz, 1H), 6.55 (d, J = 8.4
Hz, 1H), 4.04 (s, 3H), 4.01 (s, 3H), 3.97 (s, 3H). IR (neat, cm-1):
3102.2, 3065.9, 3013.2, 2991, 1594.1, 1478.7, 1319.6, 1003.7,
816.6, 734.6. HRMS (MALDI-TOF-MS): Theo. for C11H14N3O2,
[M]+:221.1164, observed:221.132.
o
capped and mixture was heated to 105 C for 3 hours. After 20
minutes a white precipitate formed. Afterwards, the mixture was
cooled down, an excess of THF was added, a white precipitate
filtered and washed with an excess of THF and dried under high
1
vacuum (302 mg, 72 %). H NMR (400 MHz, Acetonitrile-d3) δ
9.94 (s, 1H), 8.76 (s, 1H), 7.73 (d, J = 8.9 Hz, 1H), 6.81 (d, J =
2.5 Hz, 1H), 6.73 (dd, J = 9.0, 2.5 Hz, 1H), 4.00 (s, 3H), 3.99 (s,
3H), 3.89 (s, 3H). HRMS (MALDI-TOF-MS) Theo. for
C11H14N3O2,
[M]+:221.1164,
observed:
221.151.
(2-(4’,6’-difluorophen-2’-yl)pyridine)2Ir(1-(4’,6’-dimethoxyphen-2’-
ylene)-3-methyl-imidazol-2-ylidene) (Ir1). In an aluminium foil
protected 25 mL round bottom flask equipped with a stirring bar
[(dfppy)2IrCl]2 (0.2 g, 0.16 mmol) and 1-(2,4-dimethoxyphenyl)-
3-methyl-1H-imidazol-3-ium iodide (0.12 g, 0.35 mmol) were
dissolved in dichloroethane (15 mL). The solution was
deoxygenated with nitrogen for 20 minutes and then Ag2O (0.11
g, 0.49 mmol) was added and the flask was sealed with a
stopper and electrical tape. The reaction mixture was stirred at
reflux for 18 hours and then hot-filtered through celite. The
1-(6-methyl-2-methoxy-3-pyridine)imidazole
(5).
A
flask
equipped with a stirbar and reflux condenser was charged with
imidazole (1.19 g, 17.44 mmol), K2CO3 (3.01 g, 21.8 mmol), 5-
bromo-6-methyl-2-methoxypyridine (2.94 g, 2.0 mL, 14.5 mmol),
CuO (0.29 g, 3.63 mmol), and DMSO (20 mL). The reaction
mixture was then warmed to 150ºC open to air, allowed to stir,
1
and monitored by H NMR. After 16h, the reaction mixture was
cooled to room temperature, diluted with CH2Cl2 (100 mL), the
crude mixture passed through celite, washed with H2O (3 x 50
mL), and dried with MgSO4. Filtered, concentrated, and passed
the crude mixture through an SiO2 plug (75 mL) first using 20%
CH2Cl2: Hexanes (0.56g of unreacted starting material in this
fraction), CH2Cl2, and EtOAc (product in this fraction) to yield a
pale orange solid (1.35 g, 46% yield). 1H NMR (400 MHz, CDCl3)
filtrate
was
concentrated
and
purified
by
column
chromatography on silica gel and with hexane:dichloromethane
(1:3) as eluent. The product (40 mg, 14 %) was obtained as a
yellow powder. 1H NMR (400 MHz, Chloroform-d) δ 8.27 – 8.12
(m, 3H), 8.08 (d, J = 5.9 Hz, 1H), 7.78 (d, J = 5.2 Hz, 1H), 7.55
(dt, J = 16.8, 7.7 Hz, 2H), 6.79 – 6.67 (m, 2H), 6.66 (d, J = 1.9
Hz, 1H), 6.36 (dtd, J = 11.7, 9.2, 2.4 Hz, 2H), 6.17 (d, J = 2.5 Hz,
1H), 6.06 (dd, J = 7.9, 2.4 Hz, 1H), 5.98 (d, J = 2.4 Hz, 1H), 5.77
(dd, J = 8.5, 2.4 Hz, 1H), 3.90 (s, 3H), 3.56 (s, 3H), 3.15 (s, 3H).
19F NMR (376 MHz, Chloroform-d) δ -110.03 (q, J = 9.1 Hz), -
110.40 (q, J = 9.0 Hz), -110.81 (ddd, J = 12.1, 9.2, 2.8 Hz), -
111.59 (ddd, J = 12.7, 9.4, 2.8 Hz). HRMS (ESI-MS): Theo. for
C34H26F4IrN4O2, [MH]+: 791.1621, observed: 791.0087.
(2-(4’,6’-difluorophen-2’-yl)pyridine)2Ir(1-(2,6-dimethoxypyridin-3-
yl)-3-methyl-1H-imidazol-3-ium) (Ir2). The synthetic procedure
analogous for ((2-(4’,6’-difluorophen-2’-yl)pyridine)2Ir(1-(4’,6’-
dimethoxy-5’-pyridin-2’-ylene)-3-methyl-imidazol-2-ylidene) was
carried out. [(dfppy)2IrCl]2 (0.4 g, 0.33 mmol), 1-(2’,6’-
dimethoxypyridin-3’-yl)-3-methylimidazolium iodide (0.24 g, 0.69
mmol) and Ag2O (0.23 g, 0.98 mmol) in dichloroethane (15 mL)
were used. Column chromatography on silica gel with
hexane:DCM (1:2) as eluent afforded the product as a yellow
powder (95 mg, 16 %). 1H NMR (400 MHz, Chloroform-d) δ 8.26
– 8.14 (m, 2H), 8.10 (t, J = 1.4 Hz, 1H), 8.06 (d, J = 5.9 Hz, 1H),
7.72 (d, J = 5.9 Hz, 1H), 7.57 (dt, J = 16.0, 7.9 Hz, 2H), 6.78 –
6.70 (m, 2H), 6.69 (s, 1H), 6.45 – 6.28 (m, 2H), 6.05 (dd, J = 8.0,
2.3 Hz, 1H), 5.85 (d, J = 1.0 Hz, 1H), 5.73 (dd, J = 8.5, 2.3 Hz,
1H), 4.04 (s, 3H), 3.76 (s, 3H), 3.15 (s, 3H). 19F NMR (376 MHz,
Chloroform-d) δ -109.52 (q, J = 9.0 Hz), -110.07 (q, J = 9.1 Hz),
-110.62 (ddd, J = 12.6, 9.5, 2.8 Hz), -111.14 (ddd, J = 12.7, 9.6,
2.9 Hz). HRMS (ESI-MS): Theo. for C33H25F4IrN5O2, [MH]+:
δ
J = 8 Hz, 1H), 7.26 (bs, 1H), 7.04 (bs,
1H), 6.66 (d, J = 8 Hz, 1H), 3.97 (s, 3 H), 2.28 (s, 3H). 13C NMR
(100 MHz, CDCl3) δ
20.3. IR (neat, cm-1): 3117.0, 3098.2, 2988.8, 2941.9, 1580.3,
1499.1, 1474.7, 1301.3, 1030.35, 657.5. HRMS (ESI-MS): Theo.
for
C10H12N3O,
[M]+:
190.0980,
observed:190.0842.
1-(2’-methyl-6’-methoxypyridine)-3-methylimidazolium iodide (6).
A flask equipped with a stirbar was charged with 1-(2’-methyl-4’-
methoxy-3-pyridine)imidazole (0.50 g, 2.61 mmol), MeI (0.33 mL,
5.23 mmol), and MeCN (2 mL). The reaction mixture was then
1
allowed to stir at 50ºC, and monitored by H NMR. After 4h, the
reaction mixture was concentrated, and recrystallized from
CH2Cl2/Hexanes to yield an off-white solid (0.87 g, 96% yield).
1H NMR (400 MHz, CDCl3) δ
1H), 7.88-7.66 (m, 1H), 7.4-7.26 (m, 1H), 6.74 (d, J = 8 Hz, 1H),
4.31 (s, 3H) 4.00 (s, 3 H), 2.44 (s, 3H). 13C NMR (100 MHz, d6-
DMSO) δ
109.3, 54.4, 36.7, 20.3. IR (neat, cm-1): 3117.0, 3098.2, 2988.8,
2941.9, 1580.3, 1499.1, 1474.7, 1301.3, 1030.35, 657.5. IR
(neat, cm-1): 3137.1, 3072.2, 2971.9, 1583.5, 1481.6, 1307.0,
812.5, 619.2. HRMS (ESI-MS): Theo. for C11H15N3O, [M-I]+:
J = 8 Hz,
215.1215,
observed:
215.1500.
1-(2’,4’-dimethoxyphenyl)-1,2,4-triazole (7).53 The synthetic
procedure is analogous to the synthesis of 1-(2’,4’-
dimethoxyphenyl)imidazole. 1-iodo-2,6-dimethoxybenzene (2.5
g, 9.5 mmol, 1.2 equiv), 1,2,4-triazole (545 mg, 7.9 mmol, 1
equiv), K3PO4 (3.5 g, 16.6 mmol, 2.1 equiv) and CuI (75 mg, 0.4
792.1574,
observed:
792.0132.
(2-(4’,6’-difluorophen-2’-yl)pyridine)2Ir(1-(6’-methyl-4’-methoxy-
mmol,
5 %) in dry DMF (15 mL) were used. Flash
This article is protected by copyright. All rights reserved